Malnutrition and epilepsy: A two-way relationship

Clinical Nutrition

Volumn 28, Issue 3, 2009, Pages 219-225

  Crepin, Sabrina ^a   Godet, Bertrand ^a   Chassain, Benoît ^a   Preux, Pierre Marie ^b   Desport, Jean Claude ^a,b  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE LIMOGES   (France)

Author keywords

Epilepsy; Malnutrition; Nutritional deficiencies; Protein energy malnutrition; Seizure

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; STIRIPENTOL; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADD ON THERAPY; ANOREXIA; CLINICAL TRIAL; DIET THERAPY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG MEGADOSE; DYSGEUSIA; EPILEPSY; FETAL MALNUTRITION; GLOSSITIS; HUMAN; KETOGENIC DIET; MALNUTRITION; MOUTH ULCER; NONHUMAN; PATHOGENESIS; PROTEIN CALORIE MALNUTRITION; REVIEW; SIDE EFFECT; SOCIAL ISOLATION; TABOO; THERAPY EFFECT; THERAPY RESISTANCE; VITAMIN D METABOLISM; VITAMIN DEFICIENCY; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION;

ANTICONVULSANTS; COMORBIDITY; DEVELOPING COUNTRIES; EPILEPSY; HUMANS; MALNUTRITION; MICRONUTRIENTS; PROTEIN-ENERGY MALNUTRITION; PUBLIC HEALTH; TABOO;

EID: 67349133152     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.03.010     Document Type: Review

References (112)

1. The state of food insecurity in the world 2006: eradicating world hunger - taking stock ten years after the World Food Summit (2006), Food and Agriculture Organization of the United Nations p. 1-44
2. Obépi Roche. Enquête épidémiologique nationale sur le surpoids et l'obésité. Roche: Inserm, TNF Healthcare SOFRES; 2006. p. 1-52.
3. Elia M., Zellipour L., and Stratton R.J. To screen or not to screen for adult malnutrition?. Clin Nutr 24 (2005) 867-884
4. Stratton R., Green C., and Elia M. Disease-related malnutrition: an evidence-based approach to treatment (2003), CABI Publishing, Cambridge, MA, USA
5. Epilepsy: aetiogy, epidemiology and prognosis. Fact sheet (2001), Word Health Organisation
6. Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia 34 (1993) 592-596
7. Fisher R.S., van Emde Boas W., Blume W., Elger C., Genton P., Lee P., et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 46 (2005) 470-472
8. McCormick D.A., and Contreras D. On the cellular and network bases of epileptic seizures. Annu Rev Physiol 63 (2001) 815-846
9. Moody W.J., Futamachi K.J., and Prince D.A. Extracellular potassium activity during epileptogenesis. Exp Neurol 42 (1974) 248-263
10. Cohen I., Navarro V., Clemenceau S., Baulac M., and Miles R. On the origin of interictal activity in human temporal lobe epilepsy in vitro. Science 298 (2002) 1418-1421
11. Collignon F., Wetjen N.M., Cohen-Gadol A.A., Cascino G.D., Parisi J., Meyer F.B., et al. Altered expression of connexin subtypes in mesial temporal lobe epilepsy in humans. J Neurosurg 105 (2006) 77-87
12. Sloviter R.S. Hippocampal epileptogenesis in animal models of mesial temporal lobe epilepsy with hippocampal sclerosis: the importance of the "latent period" and other concepts. Epilepsia 49 Suppl. 9 (2008) 85-92
13. Asadi-Pooya A.A., and Ghaffari A. Do patients with epilepsy believe they need specific dietary restrictions?. Epilepsy Behav 5 (2004) 945-948
14. Bertoli S., Cardinali S., Veggiotti P., Trentani C., Testolin G., and Tagliabue A. Evaluation of nutritional status in children with refractory epilepsy. Nutr J 5 (2006) 14
15. Crépin S., Houinato D., Nawana B., Avode G.D., Preux P.M., and Desport J.C. Link between epilepsy and malnutrition in a rural area of Benin. Epilepsia 48 (2007) 1926-1933
16. Hackett R.J., Hackett L., and Bhakta P. The prevalence and associated factors of epilepsy in children in Calicut district, Kerala, India. Acta Paediatr 86 (1997) 1257-1260
17. Nkwetngam Ndam M. Epilepsie et statut nutritionnel dans la commune de Djidja-Département du Zou au Bénin [Thèse]. Bénin: Université d'Abomey-Calavi; 2004. p. 1-74.
18. Volpe S.L., Schall J.I., Gallagher P.R., Stallings V.A., and Bergqvist A.G. Nutrient intake of children with intractable epilepsy compared with healthy children. J Am Diet Assoc 107 (2007) 1014-1018
19. Quet F., Dalmay F., Marin B., Druet-Cabanac M., Preux P., and Network T.N. Limoges' questionnaire for investigating epilepsy: one decade on: outcomes and prospects from an analysis of 2313 questionnaires from Africa (abstract 079). Epilepsia 46 Suppl. 6 (2005) 71-72
20. Pal D.K. Methodologic issues in assessing risk factors for epilepsy in an epidemiologic study in India. Neurology 53 (1999) 2058-2063
21. Andrade J.P., and Paula-Barbosa M.M. Protein malnutrition alters the cholinergic and GABAergic systems of the hippocampal formation of the adult rat: an immunocytochemical study. Neurosci Lett 211 (1996) 211-215
22. Forbes W.B., Stern W.C., Tracy C.A., Resnick O., and Morgane P.J. Effect of chronic protein malnutrition on experimentally induced seizures in the rat. Exp Neurol 62 (1978) 475-481
23. Fukahori M., and Itoh M. Effects of dietary zinc status on seizure susceptibility and hippocampal zinc content in the El (epilepsy) mouse. Brain Res 529 (1990) 16-22
24. Georgieff M.K. Nutrition and the developing brain: nutrient priorities and measurement. Am J Clin Nutr 85 (2007) 614S-620S
25. Greene A., Todorova M., McGowan R., and Seyfried T. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 42 (2001) 1371-1378
26. Morgane P.J., Mokler D.J., and Galler J.R. Effects of prenatal protein malnutrition on the hippocampal formation. Neurosci Biobehav Rev 26 (2002) 471-483
27. Nunes M.L., Liptakova S., Veliskova J., Sperber E.F., and Moshe S.L. Malnutrition increases dentate granule cell proliferation in immature rats after status epilepticus. Epilepsia 41 Suppl. 6 (2000) S48-S52
28. Palencia G., Calvillo M., and Sotelo J. Chronic malnutrition caused by a corn-based diet lowers the threshold for pentylenetetrazol-induced seizures in rats. Epilepsia 37 (1996) 583-586
29. Savaskan N.E., Brauer A.U., Kuhbacher M., Eyupoglu I.Y., Kyriakopoulos A., Ninnemann O., et al. Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity. FASEB J 17 (2003) 112-114
30. Schwechter E., Velísková J., and Velísek L. Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann Neurol 53 (2003) 91-101
31. Schweigert I.D., de Oliveira D.L., Scheibel F., da Costa F., Wofchuk S.T., Souza D.O., et al. Gestational and postnatal malnutrition affects sensitivity of young rats to picrotoxin and quinolinic acid and uptake of GABA by cortical and hippocampal slices. Dev Brain Res 154 (2005) 177-185
32. Stern W.C., Forbes W.B., Resnick O., and Morgane P.J. Seizure susceptibility and brain amine levels following protein malnutrition during development in the rat. Brain Res 79 (1974) 375-384
33. Takeda A. Movement of zinc and its functional significance in the brain. Brain Res Brain Res Rev 34 (2000) 137-148
34. Takeda A., Itoh H., Hirate M., and Oku N. Region-specific loss of zinc in the brain in pentylentetrazole-induced seizures and seizure susceptibility in zinc deficiency. Epilepsy Res 70 (2006) 41-48
35. Wood J.H., Hare T.A., Glaeser B.S., Brooks B.R., Ballenger J.C., and Post R.M. Low cerebrospinal fluid GABA concentrations in epileptic patients: variations with respect to seizure type and chronic cerebellar stimulation. Brain Res Bull 4 (1979) 707
36. Steiger J.L., Alexander M.J., Galler J.R., Farb D.H., and Russek S.J. Effects of prenatal malnutrition on GABAA receptor alpha1, alpha3 and beta2 mRNA levels. Neuroreport 14 (2003) 1731-1735
37. Smith S.R., Pozefsky T., and Chhetri M.K. Nitrogen and amino acid metabolism in adults with protein-calorie malnutrition. Metabolism 23 (1974) 603-618
38. Agarwal K.N., Bhatia B.D., Batta R.K., Singla P.N., and Shankar R. Erythrocytic enzymes and amino acids related to glutamic acid metabolism in childhood hypoproteinemic states. Am J Clin Nutr 34 (1981) 924-927
39. Ben-Ari Y. Excitatory actions of GABA during development: the nature of the nurture. Nat Rev Neurosci 3 (2002) 728-739
40. Chandra R.K. Nutrition and the immune system: an introduction. Am J Clin Nutr 66 (1997) 460S-463S
41. Lesourd B.M., and Mazari L. Immune responses during recovery from protein-energy malnutrition. Clin Nutr 16 Suppl. 1 (1997) 37-46
42. Schelp F.P. Nutrition and infection in tropical countries - implications for public health intervention - a personal perspective. Nutrition 14 (1998) 217-222
43. Preux P.M., and Druet-Cabanac M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 4 (2005) 21-31
44. Schwartzkroin P.A., Baraban S.C., and Hochman D.W. Osmolarity, ionic flux, and changes in brain excitability. Epilepsy Res 32 (1998) 275-285
45. Castilla-Guerra L., del Carmen Fernández-Moreno M., López-Chozas J., and Fernández-Bolaños R. Electrolytes disturbances and seizures. Epilepsia 47 (2006) 1990-1998
46. Browne T.R., and Holmes G.L. Epilepsy. N Engl J Med 344 (2001) 1145-1151
47. Oguni H. Diagnosis and treatment of epilepsy. Epilepsia 45 Suppl. 8 (2004) 13-16
48. Bruce R.C., and Kliegman R.M. Hyponatremic seizures secondary to oral water intoxication in infancy: association with commercial bottled drinking water. Pediatrics 100 (1997) E4
49. Speedy D.B., Rogers I., Safih S., and Foley B. Hyponatremia and seizures in an ultradistance triathlete. J Emerg Med 18 (2000) 41-44
50. Kumar S., and Berl T. Sodium. Lancet 352 (1998) 220-228
51. Farrar H.C., Chande V.T., Fitzpatrick D.F., and Shema S.J. Hyponatremia as the cause of seizures in infants: a retrospective analysis of incidence, severity, and clinical predictors. Ann Emerg Med 26 (1995) 42-48
52. Bellazzini M.A., and Howes D.S. Pediatric hypocalcemic seizures: a case of rickets. J Emerg Med 28 (2005) 161-164
53. Bushinsky D.A., and Monk R.D. Electrolyte quintet: calcium. Lancet 352 (1998) 306-311
54. Leaver D.D., Parkinson G.B., and Schneider K.M. Neurological consequences of magnesium deficiency: correlations with epilepsy. Clin Exp Pharmacol Physiol 14 (1987) 361-370
55. Nuytten D., Van Hees J., Meulemans A., and Carton H. Magnesium deficiency as a cause of acute intractable seizures. J Neurol 238 (1991) 262-264
56. Avoli M., Drapeau C., Louvel J., Pumain R., Olivier A., and Villemure J.G. Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro. Ann Neurol 30 (1991) 589-596
57. Aguglia U., Gambardella A., Oliveri R.L., De Sarro G., Zappia M., and Quattrone A. De novo epileptic confusional status in a patient with cobalamin deficiency. Metab Brain Dis 10 (1995) 233-238
58. Biancheri R., Cerone R., Schiaffino M.C., Caruso U., Veneselli E., Perrone M.V., et al. Cobalamin (Cbl) C/D deficiency: clinical, neurophysiological and neuroradiologic findings in 14 cases. Neuropediatrics 32 (2001) 14-22
59. Johnson G.H., and Willis F. Seizures as the presenting feature of rickets in an infant. discussion. Med J Aust 178 467 (2003) 467-468
60. Karnaze D., and Carmel R. Neurologic and evoked potential abnormalities in subtle cobalamin deficiency states, including deficiency without anemia and with normal absorption of free cobalamin. Arch Neurol 47 (1990) 1008-1012
61. Keyser A., and De Bruijn S. Epileptic manifestations and vitamin B1 deficiency. Eur Neurol 31 (1991) 121-125
62. Kretsch M.J., Sauberlich H.E., and Newbrun E. Electroencephalographic changes and periodontal status during short-term vitamin B-6 depletion of young, nonpregnant women. Am J Clin Nutr 53 (1991) 1266-1274
63. Kumar S. Recurrent seizures: an unusual manifestation of vitamin B12 deficiency. Neurol India 52 (2004) 122-123
64. Ramaekers V.T., Calomme M., Vanden Berghe D., and Makropoulos W. Selenium deficiency triggering intractable seizures. Neuropediatrics 25 (1994) 217-223
65. Schweizer U., Brauer A.U., Kohrle J., Nitsch R., and Savaskan N.E. Selenium and brain function: a poorly recognized liaison. Brain Res Brain Res Rev 45 (2004) 164-178
66. Sullivan J.F., and Lankford H.G. Zinc metabolism and chronic alcoholism. Am J Clin Nutr 17 (1965) 57-63
67. Harden C.L., Rosenbaum D.H., and Daras M. Hyperglycemia presenting with occipital seizures. Epilepsia 32 (1991) 215-220
68. Keene D.L., Metrakos K., Belmonte M., Watters G.V., and Singer S. EEG abnormalities and convulsions in juvenile diabetes mellitus. Can J Neurol Sci 10 (1983) 198-199
69. Bernet-Bernady P., Tabo A., Druet-Cabanac M., Poumale F., Ndoma V., Lao H., et al. Epilepsy and its impact in northwest region of the Central African Republic. Med Trop (Mars) 57 (1997) 407-411
70. Jilek-Aall L., Jilek W., and Miller J. Clinical and genetic aspects of seizure disorders prevalent in an isolated African population. Epilepsia 20 (1979) 613-622
71. Nubukpo P., Preux P.M., Clement J.P., Houinato D., Tuillas M., Aubreton C., et al. Comparison of sociocultural attitudes towards epilepsy in Limousin (France), in Togo and in Benin (Africa). Med Trop (Mars) 63 (2003) 143-150
72. Rwiza H.T., Matuja W.B., Kilonzo G.P., Haule J., Mbena P., Mwang'ombola R., et al. Knowledge, attitude, and practice toward epilepsy among rural Tanzanian residents. Epilepsia 34 (1993) 1017-1023
73. Nubukpo P., Preux P.M., Houinato D., Radji A., Grunitzky E.K., Avode G., et al. Psychosocial issues in people with epilepsy in Togo and Benin (West Africa) I. Anxiety and depression measured using Goldberg's scale. Epilepsy Behav 5 (2004) 722-727
74. Dike G. Severe malnutrition due to subtle neurologic deficits and epilepsy: report of three cases. East Afr Med J 76 (1999) 597-598
75. Asadi-Pooya A.A., and Hossein-Zade A. What do nurses and physicians think about the need for specific dietary restrictions in patients with epilepsy?. Epilepsy Behav 6 (2005) 604-606
76. Asadi-Pooya A.A., and Sperling M.R. Do foods precipitate seizures? A cross-cultural comparison. Epilepsy Behav 11 (2007) 450-453
77. Traoré H., Diagana M., Debrock C., Ba A., Alqad B., and Preux P.M. Sociocultural approach to epilepsy in Mauritania. Med Trop (Mars) 58 (1998) 365-368
78. Watts A. The natural history of untreated epilepsy in a rural community in Africa. Epilepsia 33 (1992) 464-468
79. Ben-Menachem E., Axelsen M., Johanson E.H., Stagge A., and Smith U. Predictors of weight loss in adults with topiramate-treated epilepsy. Obes Res 11 (2003) 556-562
80. Klein K.M., Theisen F., Knake S., Oertel W.H., Hebebrand J., Rosenow F., et al. Topiramate, nutrition and weight change: a prospective study. J Neurol Neurosurg Psychiatr 79 (2008) 590-593
81. Bray G., Hollander P., Klein S., Kushner R., Levy B., Fitchet M., et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 11 (2003) 722-733
82. Reiter E., Feucht M., Hauser E., Freilinger M., and Seidl R. Changes in body mass index during long-term topiramate therapy in paediatric epilepsy patients - a retrospective analysis. Seizure 13 (2004) 491-493
83. Bergen D.C., Ristanovic R.K., Waicosky K., Kanner A., and Hoeppner T.J. Weight loss in patients taking felbamate. Clin Neuropharmacol 18 (1995) 23-27
84. Cilio M.R., Kartashov A.I., and Vigevano F. The long-term use of felbamate in children with severe refractory epilepsy. Epilepsy Res 47 (2001) 1-7
85. Faught E., Ayala R., Montouris G.G., and Leppik I.E. Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures. Neurology 57 (2001) 1774-1779
86. Gadde K.M., Franciscy D.M., Wagner II H.R., and Krishnan K.R. Zonisamide for weight loss in obese adults: a randomized controlled trial. J Am Med Assoc 289 (2003) 1820-1825
87. Chiron C., Marchand M.C., Tran A., Rey E., d'Athis P., Vincent J., et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. Lancet 356 (2000) 1638-1642
88. Gidal B.E., Maly M.M., Nemire R.E., and Haley K. Weight gain and gabapentin therapy. Ann Pharmacother 29 (1995) 1048
89. DeToledo J.C., Toledo C., DeCerce J., and Ramsay R.E. Changes in body weight with chronic, high-dose gabapentin therapy. Ther Drug Monit 19 (1997) 394-396
90. Hogan R.E., Bertrand M.E., Deaton R.L., and Sommerville K.W. Total percentage body weight changes during add-on therapy with tiagabine, carbamazepine and phenytoin. Epilepsy Res 41 (2000) 23-28
91. Hamed S.A., Fida N.M., and Hamed E.A. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain. Eur J Paediatr Neurol 13 3 (2009) 261-269
92. Gil-Nagel A., Zaccara G., Baldinetti F., and Leon T. Add-on treatment with pregabalin for partial seizures with or without generalisation: pooled data analysis of four randomised placebo-controlled trials. Seizure 18 03 (2009) 184-192
93. DRUGDEX system I D, version 5.1. Oxcarbazepine. Thomson Health Care.
94. Biton V. Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy. CNS Drugs 17 (2003) 781-791
95. Egger J., and Brett E.M. Effects of sodium valproate in 100 children with special reference to weight. Br Med J (Clin Res Ed) 283 (1981) 577-581
96. Dinesen H., Gram L., Andersen T., and Dam M. Weight gain during treatment with valproate. Acta Neurol Scand 70 (1984) 65-69
97. Chadwick D. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. Lancet 354 (1999) 13-19
98. Remy C., and Beaumont D. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy. Br J Clin Pharmacol 27 Suppl. 1 (1989) 125S-129S
99. Ben-Menachem E. Weight issues for people with epilepsy - a review. Epilepsia 48 Suppl. 9 (2007) 42-45
100. Hadjikoutis S., Pickersgill T.P., and Smith P.E. Drug points: weight loss associated with levetiracetam. Br Med J 327 (2003) 905
101. Shaibani A., Biton V., Rauck R., Koch B., and Simpson J. Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial. Eur J Pain 13 (2009) 458-463
102. Devinsky O., and Cramer J. Safety and efficacy of standard and new antiepileptic drugs. Neurology 55 (2000) S5-S10
103. DRUGDEX system I D, version 5.1. Carbamazepine. Thomson Health Care.
104. DRUGDEX system I D, version 5.1. Phenytoin. Thomson Health Care.
105. Gissel T., Poulsen C.S., and Vestergaard P. Adverse effects of antiepileptic drugs on bone mineral density in children. Expert Opin Drug Saf 6 (2007) 267-278
106. Kinsman S.L., Vining E.P., Quaskey S.A., Mellits D., and Freeman J.M. Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia 33 (1992) 1132-1136
107. Swink T.D., Vining E.P., and Freeman J.M. The ketogenic diet: 1997. Adv Pediatr 44 (1997) 297-329
108. Yudkoff M., Daikhin Y., Nissim I., Horyn O., Lazarow A., Luhovyy B., et al. Response of brain amino acid metabolism to ketosis. Neurochem Int 47 (2005) 119-128
109. Liu Y.M., Williams S., Basualdo-Hammond C., Stephens D., and Curtis R. A prospective study: growth and nutritional status of children treated with the ketogenic diet. J Am Diet Assoc 103 (2003) 707-712
110. Peterson S.J., Tangney C.C., Pimentel-Zablah E.M., Hjelmgren B., Booth G., and Berry-Kravis E. Changes in growth and seizure reduction in children on the ketogenic diet as a treatment for intractable epilepsy. J Am Diet Assoc 105 (2005) 718-725
111. Vining E.P., Pyzik P., McGrogan J., Hladky H., Anand A., Kriegler S., et al. Growth of children on the ketogenic diet. Dev Med Child Neurol 44 (2002) 796-802
112. Bough K., Schwartzkroin P., and Rho J. Calorie restriction and ketogenic diet diminish neuronal excitability in rat dentate gyrus in vivo. Epilepsia 44 (2003) 752-760